Eli Lilly and Novo Nordisk test popular drugs linked to weight loss in children
Long-term use of weight-loss drugs causes problems, doctor says Drugmakers Eli Lilly and Novo Nordisk are testing some of their most popular diabetes and weight loss drugs on patients as young as 6 years old. Lilly, based in Indiana, plans to test tirzepatide, sold under the brand name Mounjaro, on children and adolescents with type …